Treated in only 3 VISITS!   214.379.2700

Using New Techniques to Fight Prostate Cancer

The medical field has experienced a lot of success with modern treatments such as radiotherapy and surgery especially when the disease is identified early. Even so, it seems there’s still a lot to learn since cancer cells evolve so quickly, and new and innovative anticancer agents are required. Laboratory-grown prostate cancer cells have been discovered to change how research is conducted by significantly increasing the speed of trailing new drugs.

The reason why developing and testing emerging prostate cancer drugs takes so long is because prostate cancer tissue doesn’t survive outside the body. It is difficult to keep a prostate cancer tissue alive once it has been removed from a patient. Early drug screening can only be carried out on the cancer cells grown in a laboratory. Such trials may be useful but the best way to understand the effectiveness of a drug in the body is by using genuine tumor cells.

A group of researchers has developed a way to grow tumors in the laboratory from donated tumor tissues.

During the research:

  • The tissue developed was found to be complex, just like the tumors found in prostate cancer patients. This means that new drugs and the combination of drugs can be tested quickly. They’ll speed up cancer research to allow patients to benefit from scientific discoveries.
  • Existing blood cancer drugs were tested using the new prostate cancer model and the results were very encouraging. The drug combination that was used suppressed the growth of the aggressive prostate cancer cells that don’t respond to other treatments.
  • The laboratory-grown tumors have helped doctors to rapidly compare various treatments and point out those that tremendously reduce the growth of a tumor.

The researchers have a large collection of laboratory-grown prostate cancer tumors that helps them to test new ways of attacking prostate cancer and quickly and more effectively. This new methodology promises swift and better treatments for patients.